Regular Strength Aspirin EC

Product NDC: 0904-2013
11-digit product format: 009042013
Labeler code: 0904
Product ID: 0904-2013_5b957972-2d40-4946-93b2-ac620c190a1b
Type: HUMAN OTC DRUG
Nonproprietary name: Aspirin
Dosage form: TABLET, DELAYED RELEASE
Route: ORAL
Labeler: Major Pharmaceuticals
Application: part343
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2011-09-09
Marketing end: 2021-02-28
Substance: ASPIRIN
Active strength: 325 mg/1
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0904-2013		D	Discontinued by firm	2026-10-05
excluded package	package	0904-2013	0904-2013-60	D	Discontinued by firm	2026-10-05
excluded package	package	0904-2013	0904-2013-72	D	Discontinued by firm	2026-10-05
excluded package	package	0904-2013	0904-2013-80	D	Discontinued by firm	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0904-2013-60	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0904-2013-72	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0904-2013-80	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0904-2013-60	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0904-2013-72	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0904-2013-80	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0904-2013-60	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0904-2013-72	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0904-2013-80	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0904-2013-60	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0904-2013-72	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0904-2013-80	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0904-2013-60	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0904-2013-72	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0904-2013-80	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0904-2013-60	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0904-2013-72	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0904-2013-80	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0904-2013-60	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0904-2013-72	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0904-2013-80	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0904-2013-60	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0904-2013-72	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0904-2013-80	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0904-2013-60	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0904-2013-72	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0904-2013-80	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0904-2013-60	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0904-2013-72	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0904-2013-80	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0904-2013-60	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0904-2013-72	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0904-2013-80	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0904-2013-60	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0904-2013-72	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0904-2013-80	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0904-2013-60	EA - Each	0904-2013	c84ce7b9-9f6f-4975-8189-fae1baf2231b	1	2012-07-24
0904-2013-72	EA - Each	0904-2013	b1d173aa-914a-48c8-9050-e6fceae291bf	1	2012-07-24
0904-2013-80	EA - Each	0904-2013	553a24cd-9975-414f-8b60-671e643bf568	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
HYPROMELLOSE 2910 (15 MPA.S)	INACTIVE INGREDIENT	36SFW2JZ0W	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	9
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	2
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [H.J. HARKINS COMPANY, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
HYPROMELLOSE 2910 (15 MPA.S)	INACTIVE INGREDIENT	36SFW2JZ0W	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
HYPROMELLOSE 2910 (15 MPA.S)	INACTIVE INGREDIENT	36SFW2JZ0W	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
HYPROMELLOSE 2910 (15 MPA.S)	INACTIVE INGREDIENT	36SFW2JZ0W	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
HYPROMELLOSE 2910 (15 MPA.S)	INACTIVE INGREDIENT	36SFW2JZ0W	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS INC]	1
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	REGULAR STRENGTH ASPIRIN EC (ASPIRIN) TABLET, DELAYED RELEASE [PROFICIENT RX LP]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198467	aspirin 325 MG Delayed Release Oral Tablet	PSN	ae7fedff-fc8a-43fc-8b68-677ba0495518	3
198467	aspirin 325 MG Delayed Release Oral Tablet	SCD	ae7fedff-fc8a-43fc-8b68-677ba0495518	3
198467	ASA 325 MG Delayed Release Oral Tablet	SY	ae7fedff-fc8a-43fc-8b68-677ba0495518	3
198467	aspirin 325 MG Enteric Coated Oral Tablet	SY	ae7fedff-fc8a-43fc-8b68-677ba0495518	3
198467	aspirin 325 MG Delayed Release Oral Tablet	PSN	3c15ae1b-c88c-4e04-812d-91a57e77250f	2
198467	aspirin 325 MG Delayed Release Oral Tablet	PSN	8680a28c-2089-40d0-9b50-502daca07730	2
198467	aspirin 325 MG Delayed Release Oral Tablet	SCD	3c15ae1b-c88c-4e04-812d-91a57e77250f	2
198467	aspirin 325 MG Delayed Release Oral Tablet	SCD	8680a28c-2089-40d0-9b50-502daca07730	2
198467	ASA 325 MG Delayed Release Oral Tablet	SY	3c15ae1b-c88c-4e04-812d-91a57e77250f	2
198467	ASA 325 MG Delayed Release Oral Tablet	SY	8680a28c-2089-40d0-9b50-502daca07730	2
198467	aspirin 325 MG Enteric Coated Oral Tablet	SY	3c15ae1b-c88c-4e04-812d-91a57e77250f	2
198467	aspirin 325 MG Enteric Coated Oral Tablet	SY	8680a28c-2089-40d0-9b50-502daca07730	2
198467	aspirin 325 MG Delayed Release Oral Tablet	PSN	2316a3ab-b36b-4fc0-9370-b792eef4ad12	1
198467	aspirin 325 MG Delayed Release Oral Tablet	PSN	598b819f-98cd-8ecf-e053-2a91aa0aeadc	1
198467	aspirin 325 MG Delayed Release Oral Tablet	SCD	598b819f-98cd-8ecf-e053-2a91aa0aeadc	1
198467	aspirin 325 MG Delayed Release Oral Tablet	SCD	2316a3ab-b36b-4fc0-9370-b792eef4ad12	1
198467	ASA 325 MG Delayed Release Oral Tablet	SY	598b819f-98cd-8ecf-e053-2a91aa0aeadc	1
198467	ASA 325 MG Delayed Release Oral Tablet	SY	2316a3ab-b36b-4fc0-9370-b792eef4ad12	1
198467	aspirin 325 MG Enteric Coated Oral Tablet	SY	598b819f-98cd-8ecf-e053-2a91aa0aeadc	1
198467	aspirin 325 MG Enteric Coated Oral Tablet	SY	2316a3ab-b36b-4fc0-9370-b792eef4ad12	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0904-2013-60	00904201360	100 TABLET, DELAYED RELEASE in 1 BOTTLE (0904-2013-60)	2011-09-09	2021-02-28	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DRUG FACTS	Proficient Rx LP	2021-01-01	HUMAN OTC DRUG LABEL	3
Drug Facts	Bryant Ranch Prepack	2020-01-19	HUMAN OTC DRUG LABEL	4
Drug Facts	A-S Medication Solutions	2020-01-18	HUMAN OTC DRUG LABEL	3
Drug Facts	Major Pharmaceuticals	2019-10-07	HUMAN OTC DRUG LABEL	2
DRUG FACTS 170	Contract Pharmacy Services-PA \| Coupler Enterprises	2017-09-19	HUMAN OTC DRUG LABEL	1
DRUG FACTS	Aidarex Pharmaceuticals LLC	2013-11-22	HUMAN OTC DRUG LABEL	1
DRUG FACTS	Aphena Pharma Solutions - Tennessee, LLC \| Aphena Pharma Solutions - Tennessee, Inc.	2013-06-05	HUMAN OTC DRUG LABEL	2
Aspirin NSAIDS EC Tablet 325mg- 5gr	NCS HealthCare of KY, Inc dba Vangard Labs	2013-02-26	HUMAN OTC DRUG LABEL	9
DRUG FACTS	H.J. Harkins Company, Inc. \| Major Pharmaceuticals Inc \| Time Cap Labs Inc	2011-12-20	HUMAN OTC DRUG LABEL	2